F2G
Latest round
- Series H
Last raised
- Sep 2024
Total raised
- $107M
Investors
- 12
About F2G
Founded in 1998, F2G Ltd. specializes in therapeutics for fungal infections.F2G Ltd specializes in the development of novel therapeutics aimed at treating rare and life-threatening fungal infections. Their core product offerings focus on innovative antifungal agents designed to address the challenges posed by resistant fungal pathogens. These therapeutics leverage cutting-edge scientific advancements to offer patients more treatment options, particularly in cases where traditional antifungal therapies fall short. F2G’s products are primarily targeted at healthcare providers, hospitals, and specialty pharmacies within the UK and select European markets, ensuring that patients facing critical fungal infections receive timely and effective care.53 mn.F2G Ltd. The company aims to expand its market presence, specifically targeting new geographic regions in Europe and North America by 2025, enhancing access to its antifungal therapeutics for more patients in need. Their strategic focus will continue to align with their commitment to addressing rare fungal infections.
Who invested in F2G
12 investors across 2 rounds
See all investors in F2G
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about F2G
Who invested in F2G?
F2G has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has F2G raised?
F2G has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did F2G last raise money?
F2G's most recent round on record is a Series H, in Sep 2024.
What does F2G do?
F2G is a biotechnology company.
Where is F2G headquartered?
F2G is headquartered in Manchester, UK.
Which VCs invest in companies like F2G?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at F2G's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series H
Raising like F2G? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.